Skip to main content

DarioHealth Corp.

For the period ended Dec 31, 2025. Filed Mar 19, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 19, 2026

DRIO$2.06-13.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Balance Sheets

​​​​​​​
​ · ​ · December 31, · ​ · December 31,
​ · ​ ​ ​ · 2025 · ​ ​ ​ · 2024
ASSETS​​​​​​
​​​​​​​
CURRENT ASSETS: · ​ · ​ · ​ · ​
Cash and cash equivalents​$21,803​$27,764
Short-term bank deposits​​4,214​​697
Short-term restricted bank deposits​229​175
Trade receivables, net​2,144​4,804
Inventories​4,316​4,753
Other accounts receivable and prepaid expenses​2,361​2,336
​​​​​​​
Total current assets​35,067​40,529
​​​​​​​
NON-CURRENT ASSETS:​​​​
Deposits​​80​​79
Operating lease right of use assets​717​1,065
Long-term assets​​304​​313
Property and equipment, net​​549​​709
Intangible assets, net​​15,931​​18,762
Goodwill​​57,427​​57,427
​​​​​​​
Total non-current assets​​75,008​​78,355
​​​​​​​
Total assets​$110,075​$118,884

CONSOLIDATED BALANCE SHEETS

​​​​​​​
​ · ​ · December 31, · ​ · December 31,
​ · ​ ​ ​ · 2025 · ​ ​ ​ · 2024
LIABILITIES AND STOCKHOLDERS’ EQUITY · ​ · ​ · ​ · ​ · ​
​​​​​​​
CURRENT LIABILITIES: · ​ · ​ · ​ · ​
Trade payables​$2,928​$3,045
Deferred revenues​714​1,583
Operating lease liabilities​​430​​504
Other accounts payable and accrued expenses​5,251​6,052
Current maturity of long-term loan​​—​​5,451
​​​​​​​
Total current liabilities​9,323​16,635
​​​​​​​
NON-CURRENT LIABILITIES​​​​​​
Operating lease liabilities​571​765
Long-term loan​30,747​23,472
Warrant liability​​1,466​​5,968
Other long-term liabilities​46​25
​​​​​​​
Total non-current liabilities​​32,830​​30,230
​​​​​​​
STOCKHOLDERS’ EQUITY **​​​​
Common stock of $0.0001 par value - authorized: 400,000,000 shares; issued and outstanding: 6,905,948 and 1,919,420 shares on December 31, 2025 and December 31, 2024, respectively​4​4
Preferred stock of $0.0001 par value - authorized: 5,000,000 shares; issued and outstanding: 0 and 49,585 shares on December 31, 2025 and December 31, 2024, respectively​—​*) -
Additional paid-in capital​519,996​462,358
Accumulated deficit​(452,078)​(390,343)
​​​​​​​
Total stockholders’ equity​67,922​72,019
​​​​​​​
Total liabilities and stockholders’ equity​$110,075​$118,884

*) Represents an amount lower than $1.

(**) See note 1e regarding reverse share split

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.